| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.9M | +18.9% |
| Cost of Revenue | $4.7M | +7.9% |
| Gross Profit | $7.2M | +27.3% |
| R&D Expense | $1.2M | +62.1% |
| SG&A Expense | $9.0M | +34.8% |
| Operating Income | -$6.9M | +8.5% |
| Pre-tax Income | -$6.8M | +41.0% |
| Income Tax | $138K | -32.5% |
| Net Income | -$6.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.0M | -42.1% |
| Inventory | $1.7M | +41.1% |
| Current Assets | $9.5M | -34.0% |
| Total Assets | $25.6M | -14.9% |
| Current Liabilities | $2.4M | +79.9% |
| Total Liabilities | $2.9M | +65.3% |
| Stockholders' Equity | $21.0M | -21.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.6M | +39.0% |
| Capital Expenditures | $282K | — |
| Investing Cash Flow | -$1.3M | — |
| Financing Cash Flow | -$300K | -102.2% |
| Free Cash Flow | -$3.9M | — |
| +40.9% |
| EPS (Basic) | -$0.76 | +65.9% |
| EPS (Diluted) | -$0.76 | +65.9% |